CD44 and glioma: Consistent with the present findings, CD44 expression is associated with poor prognostic outcome of glioma (38, 39), BLCA (40), STAD (41, 42), HNSCC (43), KIRC (44), LIHC (45), PAAD (46),MESO (47),and THYM (48).